Best sellers

Setmelanotide is a synthetic peptide and potent melanocortin 4 receptor (MC4R) agonist studied for its ability to restore satiety signaling in rare genetic disorders such as POMC deficiency, PCSK1 deficiency, and leptin-related pathway dysfunction. It works by directly activating MC4R, bypassing upstream genetic defects that impair production of α-MSH and other satiety mediators. Research suggests that setmelanotide has significantly higher potency than endogenous α-MSH and may reduce hyperphagia and support weight loss in genetically defined obesity conditions. Its activity may be influenced by its atypical bitopic binding behavior, interacting with both orthosteric and putative allosteric receptor sites, potentially contributing to improved receptor specificity and a distinct signaling profile compared to earlier MC4R agonists.

Testagen is a bioregulatory peptide studied for its potential influence on endocrine balance, particularly in relation to thyroid hormone regulation and testosterone-related signaling. It has been described as a peptide capable of penetrating cellular structures and potentially influencing gene regulatory pathways. Research discussions suggest Testagen may support pituitary activity, increasing thyroid-stimulating hormone (TSH) output and indirectly supporting thyroid hormones T3 and T4, contributing to improved metabolism and energy regulation. It has also been explored for potential relevance in testosterone decline research, age-related vitality reduction, and hormonal imbalance-related conditions. Additional research interest includes its possible influence on hemostasis through thyroid-driven pathways and its potential immune-support relevance by modulating cellular differentiation and immune aging mechanisms.

HCG is a glycoprotein hormone studied in research contexts for its role in gonadotropin-related signaling pathways and endocrine regulatory mechanisms. It is associated with receptor-mediated processes involved in hormonal communication and system-wide endocrine coordination. Due to its well-characterized structure and role in endocrine signaling, HCG remains a key compound in experimental models investigating regulatory pathways of the hypothalamic–pituitary–gonadal axis.

GDF11 has been shown to improve the outcomes of neurodegenerative and neurovascular diseases, increase the amount of skeletal muscle and boost muscular strength. It also has the power to reverse age-related degenerative alterations, as well as govern organ and skin regeneration following damage. These are all examples of its biological effects, which include reversing senescence.

Zinc Thymulin (FTS – Zinc Complex) is a zinc-coordinated nonapeptide formulation developed for research in scalp and hair follicle biology. The complex integrates peptide-mediated immune signaling modulation with zinc-dependent enzymatic support, reflecting the multidimensional regulation of follicular growth. Within the hair follicle microenvironment, coordinated control of anagen duration, stem cell activation, oxidative balance, and microinflammatory signaling is essential for maintaining hair density and structural integrity. Zinc functions as a critical cofactor in cellular proliferation, keratin synthesis, and antioxidant defense systems, while thymulin has been investigated for its influence on immune-regulatory pathways relevant to follicular stability. Research observations suggest that zinc–thymulin complexes may contribute to maintenance of active growth-phase dynamics, support intermediate hair formation, and promote a balanced follicular microenvironment. Rather than targeting a single pathway, the formulation is studied for its integrated influence on cellular signaling, redox regulation, and micronutrient-dependent processes involved in scalp tissue homeostasis. FRESHLY PREPARED SOLUTION

Follistatin-344 is a synthetic analogue of the naturally occurring follistatin protein. In preclinical and experimental research, it has been investigated for its interactions with signaling pathways involving myostatin, activins, and follicle-stimulating hormone (FSH). Findings from in vitro and animal studies suggest that modulation of these pathways may be associated with changes in cellular differentiation processes, tissue remodeling dynamics, and selected regulatory signaling mechanisms. These observations position Follistatin-344 as a molecule of interest in research contexts focused on tissue biology, regenerative signaling, and growth-regulatory pathways.

Orexin-A (Hypocretin-1) is a neuropeptide derived from the lateral hypothalamus and plays a central role in sleep–wake regulation, arousal stability, and autonomic balance. It interacts with orexin receptors OXR1 and OXR2 and modulates key neurotransmitter systems including dopamine, norepinephrine, serotonin, and histamine. Experimental research has examined Orexin-A in models of narcolepsy, sleep–wake dysregulation, neuroinflammation, thermoregulation, and autonomic control. Due to its ability to cross the blood–brain barrier, Orexin-A remains a molecule of interest in central nervous system signaling research. Orexin-B (Hypocretin-2) is a hypothalamic neuropeptide primarily interacting with the orexin receptor OXR2, contributing to sleep–wake homeostasis and arousal regulation. Unlike Orexin-A, Orexin-B exhibits receptor selectivity toward OXR2, making it a valuable tool for receptor-specific signaling studies. Preclinical research has investigated Orexin-B in the context of narcolepsy models, vigilance state regulation, autonomic modulation, and neuroendocrine signaling. Its receptor selectivity provides insight into differential orexin pathway activation in sleep and arousal research. FRESHLY PREPARED SOLUTION

Livagen is a short bioregulatory peptide that has been investigated in experimental research for its influence on DNA organization and gene expression. It is primarily recognized for its association with chromatin decondensation, a process that increases DNA accessibility and has been linked to cellular profiles typically observed in younger cells. Scientific research has focused predominantly on immune system lymphocytes, where Livagen has been shown to modulate gene activity and cellular function. Through these mechanisms, Livagen has been studied for its involvement in biological processes related to immune regulation and signaling pathways associated with cardiovascular, gastrointestinal, neurological, and immune system function. Experimental findings have also explored Livagen’s role in nociception and pain-related signaling. Ongoing research continues to examine Livagen’s broader relevance in studies of aging, cellular senescence, and long-term biological regulation. FRESHLY PREPARED SOLUTION

Cortagen has been investigated in preclinical and exploratory research settings for its potential involvement in brain reparative processes, cerebroprotective responses, and nootropic-like activity, within experimental models of cerebral stress and degeneration. Research literature has explored Cortagen in relation to the following neurobiological contexts: Cerebral lesion and injury models Neurodegenerative and dementing process models, including protein-aggregation and vascular-associated degeneration Extrapyramidal and movement-disorder research models Spinal and cerebellar system dysfunction models Central nervous system involvement in immune-mediated and inflammatory conditions Motor impairment and hemiplegia-related models Paralytic and neuromuscular dysfunction models Cerebral involvement in bacterial meningeal inflammation models Hemorrhagic cerebral stress models Transient and persistent cerebral ischemia models  FRESHLY PREPARED SOLUTION 

MIF-1 (Melanocyte-Inhibiting Factor 1) has been investigated for its role in central nervous system signaling and neuronal regulation. Scientific studies have examined MIF-1 in relation to multiple biological processes associated with brain function, neurochemical balance, and cellular resilience. Research has primarily focused on MIF-1 in the context of the following areas: Neurotransmitter Modulation: Associated with the regulation of dopamine and serotonin signaling pathways involved in motor function and mood-related processes. Neuroplasticity: Linked to mechanisms that support synaptic plasticity relevant to learning and memory in experimental research. Neuroprotective Activity: Studied for its involvement in cellular pathways that help protect neurons from oxidative and inflammatory stress. Neuroregenerative Processes: Investigated for its role in mechanisms related to neuronal repair and cellular renewal in research models of neural injury. Mood-Related Signaling: Explored for its influence on neurochemical pathways associated with emotional regulation and stress responses. Cognitive Function: Associated in experimental settings with processes relevant to memory, attention, and higher-order cognitive performance. Neurodegenerative Research: Examined in studies focused on biological pathways involved in neurodegenerative conditions and age-related neural changes.

Ovagen is a bioregulatory peptide that has been studied for its role in supporting gastrointestinal mucosal integrity and maintaining normal liver tissue structure. Research suggests it may help protect the gastrointestinal mucosal layer from stressors such as antibiotics, toxins, and anti-inflammatory agents, while also being associated with reduced fibrotic processes in liver tissue. Ongoing experimental studies are further evaluating Ovagen’s interaction with mechanisms involved in HIV viral replication.

Adenosine monophosphate (AMP) has a well-known experimental analog in the molecule AICAR. In preclinical research models, AICAR has been extensively used to investigate AMPK-mediated cellular energy regulation, metabolic stress responses, and redox balance. In in vitro systems and animal studies, AICAR has been evaluated in experimental contexts related to cardiac ischemia models, where AMPK activation has been associated with modulation of cellular survival pathways under ischemic stress. Due to its role in regulating oxidative stress and energy metabolism, AICAR has also been studied in experimental ageing-related models, as well as in preclinical models of metabolic and inflammatory dysregulation, including those used to investigate mechanisms relevant to insulin signaling, immune activation, and chronic inflammation. These findings are limited to controlled laboratory and animal research settings and are used to explore underlying biological mechanisms rather than clinical applications.

Taltirelin is a synthetic TRH analogue studied primarily for its effects in spinocerebellar degeneration and related motor coordination disorders. Acting as a biased superagonist at TRH-R1, it influences central neurotransmission and has been investigated for neuroprotective, anti-ataxic, and pro-cognitive effects. Research suggests taltirelin may modulate multiple neurotransmitter systems, including acetylcholine, dopamine, serotonin, and noradrenaline, contributing to interest in its potential relevance for memory impairment, depressive-like conditions, arousal regulation, and fatigue-related disorders. Additional studies have explored its antinociceptive properties and possible effects on neurite outgrowth and spinal cord-related neural recovery, making it a notable peptide in experimental research involving neurodegeneration, cognition, and neurological resilience. FRESHLY PREPARED SOLUTION

GHRP-6 is a synthetic hexapeptide classified as a growth hormone secretagogue and a selective agonist of the ghrelin receptor (GHS-R1a). It is studied in research contexts for its interaction with receptor-mediated signaling pathways involved in endocrine regulation and neuroendocrine communication processes. Due to its well-characterized receptor activity, GHRP-6 remains a compound of interest in experimental models investigating ghrelin-related signaling and growth hormone regulatory pathways.

Adenosine monophosphate (AMP) has a well-known experimental analog in the molecule AICAR. In preclinical research models, AICAR has been extensively used to investigate AMPK-mediated cellular energy regulation, metabolic stress responses, and redox balance. In in vitro systems and animal studies, AICAR has been evaluated in experimental contexts related to cardiac ischemia models, where AMPK activation has been associated with modulation of cellular survival pathways under ischemic stress. Due to its role in regulating oxidative stress and energy metabolism, AICAR has also been studied in experimental ageing-related models, as well as in preclinical models of metabolic and inflammatory dysregulation, including those used to investigate mechanisms relevant to insulin signaling, immune activation, and chronic inflammation. These findings are limited to controlled laboratory and animal research settings and are used to explore underlying biological mechanisms rather than clinical applications.   FRESHLY PREPARED SOLUTION 

Chonluten has been explored in relation to the regulation of pulmonary mucosa, gene networks involved in inflammatory and antioxidant processes, and tissue adaptation mechanisms across a broad range of acute and chronic respiratory and systemic stress conditions, of both infectious and non-infectious origin, including age-associated functional decline. Experimental findings indicate a predominant activity within pulmonary tissue, with secondary involvement observed in the gastrointestinal tract. Specifically, Chonluten has been studied in preclinical research contexts involving: post-infectious pulmonary recovery states chronic cardiopulmonary functional impairment persistent respiratory dysfunction recovery phases following prolonged mechanical ventilation long-term pulmonary adaptation after remission of granulomatous conditions acute respiratory distress and hypoxia-associated states high physiological load and exercise-related respiratory stress maintenance of respiratory function in ageing biological systems inflammation-driven pulmonary mucosal dysregulation inflammatory states and alterations of the gastrointestinal mucosa FRESHLY PREPARED SOLUTION 

Cardiogen is a short synthetic peptide used in preclinical research models to study fibroblast-associated signaling and tissue remodeling mechanisms. In in vitro systems and animal studies, it has been investigated for its role in regulating cellular processes involved in extracellular matrix organization and scar-related responses under experimental conditions. FRESHLY PREPARED SOLUTION 

SLU-PP-332 is a synthetic small-molecule research compound best known as a pan-agonist of ERRα, ERRβ, and ERRγ, a family of nuclear receptors involved in mitochondrial function, oxidative metabolism, and cellular energy regulation. Its main interest lies in its ability to shift tissues toward a more oxidative metabolic state. Rather than acting like a stimulant, it appears to influence upstream transcriptional programs that regulate how cells produce and use energy. This includes effects on mitochondrial biogenesis, fatty acid oxidation, oxidative phosphorylation, and overall fuel preference. In preclinical studies, SLU-PP-332 has been associated with increased mitochondrial respiration, enhanced oxidative muscle remodeling, greater reliance on fat oxidation, higher energy expenditure, and improved endurance-related parameters in animal models. It has also shown activity in experimental settings involving metabolic dysfunction, liver fat accumulation, cardiac energy impairment, and age-related mitochondrial decline. Overall, SLU-PP-332 is best described as a preclinical metabolic reprogramming compound with exercise-mimetic and oxidative metabolic activity. It is relevant for research into mitochondrial biology, fuel utilization, and ERR-driven transcriptional regulation.

TAT-CBD3 is a cell-penetrating peptide designed to modulate neuropathic pain by selectively disrupting the interaction between CRMP-2 and CaV2.2 voltage-gated calcium channels. By reducing calcium influx and excitatory neurotransmitter release, it decreases nociceptor hyperexcitability and abnormal pain signaling. Unlike conventional analgesics, TAT-CBD3 targets upstream molecular mechanisms involved in pain transmission, offering a more selective neuromodulatory approach. Preclinical studies have demonstrated its ability to reduce key features of neuropathic pain, including allodynia, hyperalgesia, and hypersensitivity.

1 box/50 Pieces

1 box/5 Pieces

B7-33 has been investigated in preclinical research models related to: Fibrotic tissue remodeling models Vascular protection and endothelial signaling models Cardiac injury and post-ischemic remodeling models Pulmonary inflammation and fibrosis-related models  FRESHLY PREPARED SOLUTION 

Oxytocin is a multifunctional peptide hormone and neuropeptide involved in a wide range of physiological and psychological processes. Synthesized in the hypothalamus and released by the posterior pituitary gland, it acts both peripherally and within the central nervous system. Research has associated oxytocin with the following effects: Exhibits anti-inflammatory properties that support wound healing and tissue regeneration Enhances trust, empathy, and social recognition involved in interpersonal bonding Improves recognition of emotional expressions, supporting effective social communication Modulates neurotransmitter systems such as dopamine and serotonin, contributing to mood balance and stress reduction Has been investigated for potential roles in reducing symptoms associated with anxiety and depressive states Contributes to sexual receptivity and reproductive behaviors in both men and women Reduces activity of the amygdala, which is associated with fear and anxiety responsesInduces uterine contractions during labor and mediates milk ejection during breastfeeding FRESHLY PREPARED SOLUTION 

ATN-161 is a synthetic pentapeptide used in preclinical research models to study integrin–extracellular matrix interactions, particularly those involving fibronectin binding. In in vitro systems and animal studies, modulation of these interactions has been employed to investigate cell adhesion, migration, angiogenesis-related signaling, and tissue remodeling mechanisms under experimental conditions.